257 related articles for article (PubMed ID: 26359459)
1. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
[TBL] [Abstract][Full Text] [Related]
2. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
[TBL] [Abstract][Full Text] [Related]
3. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
4. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
[TBL] [Abstract][Full Text] [Related]
7. The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
Liu X; Chen B; You W; Xue S; Qin H; Jiang H
Cancer Lett; 2018 Jan; 412():194-207. PubMed ID: 29074425
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
Liu F; Zhang H; Song H
Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
[TBL] [Abstract][Full Text] [Related]
9. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
Lukashova V; Chen Z; Duhé RJ; Rola-Pleszczynski M; Stanková J
J Immunol; 2003 Oct; 171(7):3794-800. PubMed ID: 14500680
[TBL] [Abstract][Full Text] [Related]
10. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
[TBL] [Abstract][Full Text] [Related]
11. The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells.
Kucuksayan H; Akca H
Tumour Biol; 2017 Sep; 39(9):1010428317706212. PubMed ID: 28937318
[TBL] [Abstract][Full Text] [Related]
12. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
13. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop.
Liu X; Wang J; Wang H; Yin G; Liu Y; Lei X; Xiang M
Cancer Lett; 2015 Jun; 362(1):45-60. PubMed ID: 25779676
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma.
Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhang C; Hou J; Zhan Q
Oncogene; 2015 Oct; 34(40):5114-27. PubMed ID: 25639872
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.
Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z
Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells.
Li J; Lan T; Zhang C; Zeng C; Hou J; Yang Z; Zhang M; Liu J; Liu B
Oncotarget; 2015 Jan; 6(2):1031-48. PubMed ID: 25504436
[TBL] [Abstract][Full Text] [Related]
19. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
[TBL] [Abstract][Full Text] [Related]
20. An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells.
Yang L; Han S; Sun Y
Biochem Biophys Res Commun; 2014 Oct; 453(3):582-7. PubMed ID: 25285632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
